Read More Pharma Industry News TerSera Therapeutics real-world ziconotide data at ASPN 2025 shows rising guideline-based intrathecal pain therapy adoption TerSera Therapeutics highlights real-world ziconotide prescribing trends at ASPN 2025, signaling growing guideline-aligned adoption in chronic pain management. byPallavi MadhirajuJuly 19, 2025